Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimised Decrement Evoked Potential (DeEP) Mapping to Guide Ventricular Tachycardia (VT) Ablation in Patients With Structural Heart Disease VT

NCT06937983 is registered in ClinicalTrials.gov with University Hospitals Coventry and Warwickshire NHS Trust as lead sponsor.

NCT NCT06937983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06937983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimised Decrement Evoked Potential (DeEP) Mapping to Guide Ventricular Tachycardia (VT) Ablation in Patients With Structural Heart Disease VT
Lead sponsor
University Hospitals Coventry and Warwickshire NHS Trust
Phase
Not applicable
Overall status
Recruiting
Start date
April 11, 2025
Completion date
December 3, 2027
Enrollment
77 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

structural heart disease